Please Wait
Applying Filters...
Menu

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”
This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

Impressions: 4871

https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

Radio Compass
16 Dec 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
FDA’s landmark approvals of BMS’ schizo med, Madrigal’s MASH drug, US$ 16.5 bn Catalent buyout make it to top 10 news of 2024
The year 2024 was marked by some landmark drug approvals in the areas of schizophrenia, metabolic dysfunction-associated steatohepatitis (MASH), chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease. The incoming Trump administration, monkeypox outbreak and drug price negotiations in the US also created big news. Here is PharmaCompass’ compilation of the top 10 news from Phispers of 2024. I. BMS’ US$ 14 bn Karuna bet pays off with landmark FDA approval for schizophrenia med Cobenfy The US Food and Drug Administration’s groundbreaking approval of Bristol Myers Squibb’s Cobenfy to treat schizophrenia has made it to our number one spot. BMS had acquired Cobenfy through its US$ 14 billion purchase of Karuna Therapeutics, announced in December 2023. Cobenfy is the first-ever antipsychotic that targets cholinergic receptors. Cobenfy’s new approach has experts excited. Its peak sales are expected to come in at US$ 7.5 billion a year. While BMS’ Karuna buyout paid off, AbbVie’s US$ 8.7 billion acquisition of Cerevel Therapeutics was dampened when their lead candidate and schizophrenia drug emraclidine failed to meet phase 2 endpoints in two pivotal trials. II. 2024’s biggest deal, US$ 16.5 bn Catalent buyout by Novo’s parent, cleared after intense scrutiny  On number two spot is Novo Nordisk Foundation’s acquistion of Catalent via its investment arm Novo Holdings for US$ 16.5 billion, announced in February 2024. Novo Holdings plans to sell three of Catalent’s “fill-finish” sites to Novo Nordisk for US$ 11 billion. Easily the biggest biopharma acquisition of last year, the deal  faced criticism from lawmakers and consumer groups for its potential anti-competitive effects, particularly in the glucagon-like peptide-1 (GLP-1) drug market. Its main competitor Eli Lilly called for scrutiny by competition regulators. However, in December, both the EU regulator and the US Federal Trade Commission gave it the greenlight. III. Madrigal’s Rezdiffra becomes first FDA-approved drug for liver disease MASH For quite some time, the drug development field for the liver condition MASH had been a graveyard for failed programs. In 2024, the field celebrated a hurrah moment when Madrigal’s oral drug Rezdiffra became the first treatment in the US for adults with this common fatty liver disease. The approval has opened a multi-billion dollar opportunity for Madrigal with the American Liver Foundation CEO Lorraine Stiehl calling it a “game-changing” moment. IV. COPD patients get two new treatments — Verona’s Ohtuvayre and Sanofi-Regeneron’s Dupixent The COPD landscape saw remarkable advances in 2024. FDA approved Verona Pharma’s Ohtuvayre, which brings the first new mechanism of action in over two decades for the treatment of COPD. This dual-action, inhaled medication serves as both a bronchodilator and an anti-inflammatory agent, offering a comprehensive approach to symptom management. Adding to this progress, Sanofi and Regeneron’s Dupixent achieved a historic milestone by becoming the first biologic approved for treating COPD. Over 390 million people are living with COPD worldwide. V. Novartis inks 20 deals in 2024, promises over US$ 25 billion in biobucks, lays bets on radiopharmas Novartis has been investing in early-stage science, buying out companies in the sub-US$ 5 billion range. The Swiss drugmaker Novartis inked over 20 deals in 2024, paying over US$ 5.5 billion upfront and promising over US$ 25 billion in biobucks. The company has particularly focused on radiopharmaceuticals and molecular glue degraders. It acquired Mariana Oncology to strengthen its radioligand therapy (RLT) pipeline, and also inked RLT deals with PeptiDream and Ratio Therapeutics. VI. Despite political pressure, FDA rejects first MDMA-assisted therapy to treat PTSD; Lykos faces expanded probe In August, FDA declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat post-traumatic stress disorder (PTSD). In the lead-up to the FDA decision, 80 members of Congress from both sides of the aisle had urged US President Joe Biden and the FDA to consider further studies on the therapy. Not satisfied with just declining Lykos’ MDMA-assisted therapy for PTSD, FDA had expanded its investigation into the clinical trials that tested it. Lykos CEO Amy Emerson stepped down after reducing its workforce by 75 percent. Additionally, its founder Rick Doblin exited its board. VII. Alzheimer’s gets two new treatments as FDA approves Lilly’s Kisunla, Alpha Cognition’s Zunveyl FDA finally approved Eli Lilly’s Alzheimer’s drug Kisunla in July, after delaying action on it in March. This approval, along with that of Biogen and Eisai’s Leqembi in 2023, mark successes in treating the mind-wasting disease after three decades of failed efforts. FDA also approved Alpha Cognition’s Zunveyl to treat mild-to-moderate Alzheimer’s disease. Zunveyl is a prodrug of Alzheimer’s medication galantamine, and is to be taken orally twice a day. Alpha said Zunveyl is designed to address the tolerability issues with galantamine. VIII. IRA price talks conclude; Stelara, Enbrel, Eliquis to bring 51.4% of Medicare savings After filing futile lawsuits questioning the constitutional validity of the Medicare drug price negotiations under the Inflation Reduction Act (IRA), all drug companies came to the bargaining table. In August, the Biden-Harris Administration announced it had reached agreements for lower prices for all 10 drugs selected for negotiations under the IRA. The new prices come into effect from January 1, 2026. A Brookings Institution report said that just three drugs will account for over half of the expected US$ 6 billion savings in 2026. J&J’s Stelara (US$ 1.4 billion), Amgen’s Enbrel (US$ 1.1 billion), and BMS’ Eliquis (US$ 856 million) are expected to account for US$ 3.28 billion or 51.4 percent of Medicare savings. IX. Trump’s picks for new administration send shockwaves across markets, stocks of vaccine makers tumble  Donald Trump’s picks for his new administration not only created big news, but also impacted the stock markets. His selection of Robert F. Kennedy Jr., an anti-vaccine activist, to lead the Department of Health and Human Services (HHS), sent shares of several vaccine manufacturers plummeting. In the US, stocks of Pfizer, Moderna, and Novavax dipped. In Europe, stocks of BioNTech, GSK, and Bavarian Nordic tumbled. Trump has nominated Mehmet Oz, a celebrity TV host, to run the Centers for Medicare and Medicaid Services (CMS), which oversees health insurance. X. New mpox outbreak in Africa sparks global response; FDA approves Emergent’s vaccine to treat mpox In August, a new mpox virus clade put Africa in the throes of an mpox outbreak. The WHO declared it a public health emergency of international concern. Emergent BioSolutions said it will donate 50,000 doses of its smallpox vaccine ACAM2000. Multiple countries responded with donations of Bavarian Nordic’s Jynneos, the only widely-approved mpox vaccine at the time. In early September, the FDA approved Emergent’s ACAM2000 as the second mpox vaccine.

Impressions: 1924

https://www.pharmacompass.com/radio-compass-blog/fda-s-landmark-approvals-of-bms-schizo-med-madrigal-s-mash-drug-us-16-5-bn-catalent-buyout-make-it-to-top-10-news-of-2024

#Phispers by PHARMACOMPASS
02 Jan 2025

NEWS #PharmaBuzz

[Sponsored by another company]read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411

FDA
22 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411

FDA
24 Jun 2020

https://www.pharmacompass.com/pdf/news/sigma-tau-arzneimittel-gmbh-chenodeoxycholic-acid-sigma-tau-receives-approval-in-europe-1494071739.pdf

EMA
05 May 2017

http://www.pmlive.com/pharma_appointments/sigma-tau_pharmaceuticals_appoints_ceo_1091722

PM LIVE
08 Aug 2016
Contact Sigma Tau and get a quotation

Sigma Tau is a supplier offers 154 products (APIs, Excipients or Intermediates).

Find a price of Acetylcholine Chloride bulk offered by Sigma Tau

Find a price of 2-Deoxy-D-Glucose bulk offered by Sigma Tau

Find a price of 2-Deoxycytidine bulk offered by Sigma Tau

Find a price of 6-Aminonicotinamide bulk offered by Sigma Tau

Find a price of 6-Mph4 bulk offered by Sigma Tau

Find a price of Acetohydroxamic Acid bulk offered by Sigma Tau

Find a price of Adenine bulk offered by Sigma Tau

Find a price of Adenosine bulk offered by Sigma Tau

Find a price of Alpha Lipoic Acid bulk offered by Sigma Tau

Find a price of Alpha-D-Galactose bulk offered by Sigma Tau

Find a price of Alpha-Linolenic Acid bulk offered by Sigma Tau

Find a price of Aminooxyacetic Acid bulk offered by Sigma Tau

Find a price of Ammonium Chloride bulk offered by Sigma Tau

Find a price of Amphetamine bulk offered by Sigma Tau

Find a price of Angiotensinogen bulk offered by Sigma Tau

Find a price of Apomorphine Hydrochloride bulk offered by Sigma Tau

Find a price of Aprotinin bulk offered by Sigma Tau

Find a price of Arecoline Hydrobromide bulk offered by Sigma Tau

Find a price of Aspartic Acid API bulk offered by Sigma Tau

Find a price of Aspartyl Adenylate bulk offered by Sigma Tau

Find a price of Atropine bulk offered by Sigma Tau

Find a price of Bacitracin Zinc bulk offered by Sigma Tau

Find a price of Beta Nicotinamide Adenine Dinucleotide bulk offered by Sigma Tau

Find a price of Betaine bulk offered by Sigma Tau

Find a price of Biotin bulk offered by Sigma Tau

Find a price of Bovine Insulin bulk offered by Sigma Tau

Find a price of Bradykinin bulk offered by Sigma Tau

Find a price of Carbodiimide, Hydrochloride bulk offered by Sigma Tau

Find a price of CAS 50-28-2 bulk offered by Sigma Tau

Find a price of CAS 643-79-8 bulk offered by Sigma Tau

Find a price of Catalase bulk offered by Sigma Tau

Find a price of Cholesterol bulk offered by Sigma Tau

Find a price of Cholic Acid bulk offered by Sigma Tau

Find a price of Choline Chloride bulk offered by Sigma Tau

Find a price of Collagenase Inhibitor bulk offered by Sigma Tau

Find a price of Corticosterone bulk offered by Sigma Tau

Find a price of Coumarin bulk offered by Sigma Tau

Find a price of Cycloheximide bulk offered by Sigma Tau

Find a price of Cysteamine Hydrochloride bulk offered by Sigma Tau

Find a price of D-Gluconic Acid bulk offered by Sigma Tau

Find a price of D-Phenylalanine API bulk offered by Sigma Tau

Find a price of Delta-Aminolevulinic Acid HCl bulk offered by Sigma Tau

Find a price of Deoxyuridine bulk offered by Sigma Tau

Find a price of Deuterium Oxide bulk offered by Sigma Tau

Find a price of Dextromethorphan Hydrobromide bulk offered by Sigma Tau

Find a price of Diatrizoate Sodium bulk offered by Sigma Tau

Find a price of Diethanolamine Triiodothyroacetate bulk offered by Sigma Tau

Find a price of Dihydrotestosterone bulk offered by Sigma Tau

Find a price of Dihydroxyphenylethylene Glycol bulk offered by Sigma Tau

Find a price of Dimethyl Sulfoxide bulk offered by Sigma Tau

Find a price of Dimethyltryptamine bulk offered by Sigma Tau

Find a price of Dipyridamole bulk offered by Sigma Tau

Find a price of Disodium Succinate bulk offered by Sigma Tau

Find a price of Dl-5-Fluorotryptophan bulk offered by Sigma Tau

Find a price of Dl-Beta-Hydroxybutyric Acid Sodium Salt bulk offered by Sigma Tau

Find a price of DL-Ornithine hydrochloride bulk offered by Sigma Tau

Find a price of Dl-Phenylalanine bulk offered by Sigma Tau

Find a price of Dl-Threo-3,4-Dihydroxyphenylserine bulk offered by Sigma Tau

Find a price of Dodecyl Maltoside bulk offered by Sigma Tau

Find a price of Enkephalin, Methionine bulk offered by Sigma Tau

Find a price of Fampridine bulk offered by Sigma Tau

Find a price of Fructose 1,6-Bisphosphate Sodium bulk offered by Sigma Tau

Find a price of Fusaric Acid bulk offered by Sigma Tau

Find a price of Glucosidase Inhibitor, 6F bulk offered by Sigma Tau

Find a price of Glutathione bulk offered by Sigma Tau

Find a price of Glycine bulk offered by Sigma Tau

Find a price of Hepes Sodium Salt bulk offered by Sigma Tau

Find a price of Hyaluronidase bulk offered by Sigma Tau

Find a price of Hydrazine bulk offered by Sigma Tau

Find a price of Indomethacin bulk offered by Sigma Tau

Find a price of Inosine bulk offered by Sigma Tau

Find a price of Inositol bulk offered by Sigma Tau

Find a price of Isoleucine bulk offered by Sigma Tau

Find a price of Isoniazid bulk offered by Sigma Tau

Find a price of Ketoleucine bulk offered by Sigma Tau

Find a price of L-Alanine API bulk offered by Sigma Tau

Find a price of L-Arginine Hydrochloride API bulk offered by Sigma Tau

Find a price of L-Carnitine HCl bulk offered by Sigma Tau

Find a price of L-Cysteine bulk offered by Sigma Tau

Find a price of L-Glutamic Acid bulk offered by Sigma Tau

Find a price of L-Leucine API bulk offered by Sigma Tau

Find a price of L-Methionine bulk offered by Sigma Tau

Find a price of L-Threonine bulk offered by Sigma Tau

Find a price of L-Tyrosine API bulk offered by Sigma Tau

Find a price of L-VALINE bulk offered by Sigma Tau

Find a price of Levocarnitine bulk offered by Sigma Tau

Find a price of Levodopa Methyl Ester bulk offered by Sigma Tau

Find a price of Lysine Hydrochloride bulk offered by Sigma Tau

Find a price of Macrogol bulk offered by Sigma Tau

Find a price of Melatonin bulk offered by Sigma Tau

Find a price of Mercaptopurine bulk offered by Sigma Tau

Find a price of Mesalazine bulk offered by Sigma Tau

Find a price of Meso-2,3-Dimercaptosuccinic Acid bulk offered by Sigma Tau

Find a price of Methacholine Chloride bulk offered by Sigma Tau

Find a price of Methotrexate bulk offered by Sigma Tau

Find a price of Methylcobalamin bulk offered by Sigma Tau

Find a price of Naloxone Hydrochloride bulk offered by Sigma Tau

Find a price of Nicotine bulk offered by Sigma Tau

Find a price of Orotic Acid bulk offered by Sigma Tau

Find a price of Pantethine bulk offered by Sigma Tau

Find a price of Penicillamine bulk offered by Sigma Tau

Find a price of Pentetic Acid bulk offered by Sigma Tau

Find a price of Phenazon bulk offered by Sigma Tau

Find a price of Phenethylamine bulk offered by Sigma Tau

Find a price of Phenolphthalein Glucuronide bulk offered by Sigma Tau

Find a price of Phenylacetic Acid bulk offered by Sigma Tau

Find a price of Phenylalanine bulk offered by Sigma Tau

Find a price of Physostigmine Salicylate bulk offered by Sigma Tau

Find a price of Prasterone Acetate bulk offered by Sigma Tau

Find a price of Progesterone bulk offered by Sigma Tau

Find a price of Proline bulk offered by Sigma Tau

Find a price of Pyridoxal Phosphate bulk offered by Sigma Tau

Find a price of Pyridoxine Hydrochloride bulk offered by Sigma Tau

Find a price of Quinacrine bulk offered by Sigma Tau

Find a price of Serine bulk offered by Sigma Tau

Find a price of Sodium 4-Aminobenzoate bulk offered by Sigma Tau

Find a price of Sodium Butyrate bulk offered by Sigma Tau

Find a price of Sodium Deoxycholate bulk offered by Sigma Tau

Find a price of Sodium DNA bulk offered by Sigma Tau

Find a price of Sodium Oxybate bulk offered by Sigma Tau

Find a price of Sodium Pyruvate bulk offered by Sigma Tau

Find a price of Somatostatin bulk offered by Sigma Tau

Find a price of Stearylamine bulk offered by Sigma Tau

Find a price of Taurine bulk offered by Sigma Tau

Find a price of Testosterone bulk offered by Sigma Tau

Find a price of Thiazolidine-4-Carboxylic Acid bulk offered by Sigma Tau

Find a price of Thymidine bulk offered by Sigma Tau

Find a price of Tiratricol bulk offered by Sigma Tau

Find a price of Trimethoprim bulk offered by Sigma Tau

Find a price of Triolein bulk offered by Sigma Tau

Find a price of Tris Hydrochloride API bulk offered by Sigma Tau

Find a price of Tromethamine API bulk offered by Sigma Tau

Find a price of Trypsin bulk offered by Sigma Tau

Find a price of Tryptophan bulk offered by Sigma Tau

Find a price of Tyramine Hydrochloride bulk offered by Sigma Tau

Find a price of Uridine bulk offered by Sigma Tau

Find a price of Yohimbine Hydrochloride bulk offered by Sigma Tau

Find a price of L-ALPHA-PHOSPHATIDYL CHOLINE TYPE II-S bulk offered by Sigma Tau

Find a price of AMINO ACIDS: L-ARGININE, FREE BASE AND L-ARGININE, HYDROCHLORIDE bulk offered by Sigma Tau

Find a price of L-ALPHA-PHOSPHATIDYLCHOLINE TYPE XIII-E MDG. IN MISSOURI bulk offered by Sigma Tau

Find a price of D (-)-RIBOSE PRODUCT # R 7500 FD bulk offered by Sigma Tau

Find a price of MUSCIMOL bulk offered by Sigma Tau

Find a price of BETA-GLYCEROPHOSPHATE GRADE XII CALCIUM SALT bulk offered by Sigma Tau

Find a price of ETIOCHOLAAN-3 ALPHA-OL-17-ONE bulk offered by Sigma Tau

Find a price of TES(N-tris[ HYRDOXYMETHYL ] methy 2-aminoethanesulfonic acid) bulk offered by Sigma Tau

Find a price of BETA-AMINOPROPIONITRILE MONOFUMARARTE SALT bulk offered by Sigma Tau

Find a price of POLY (ALA,GLU,LYS-HBR,TYR) 6:2:5:1 bulk offered by Sigma Tau

Find a price of DIETHYLENETRIAMINE PENTACETIC ACID TRISODIUM ZINC SALT, 0.5 MOLAR SOL. bulk offered by Sigma Tau

Find a price of METHYLENE DIPHOSPHORIC ACID bulk offered by Sigma Tau

Find a price of AMINO ACIDS & THEIR SODIUM SALT DERIVATIVES RELATIVE TO HFN-130 INDs bulk offered by Sigma Tau

Find a price of 2,2'-(ETHYLENEDIIMINO) DIBUTYRIC ACID bulk offered by Sigma Tau

Find a price of OLEIC ACID SODIUM 95% bulk offered by Sigma Tau

Find a price of ETHANOL SOLUTION OF CARDIOLIPIN SODIUM SALT (SIGMA CHEMICAL COMPANY) bulk offered by Sigma Tau

Find a price of DIAMINE OXIDASE bulk offered by Sigma Tau